Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS (CURRENT/OASIS7)

Clinical Trial ID NCT00335452

Rank	Title	Journal	Year	PubWeight™‹?›
1	Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.	N Engl J Med	2010	6.05
2	Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.	Lancet	2010	5.30
3	Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.	Diabetes Care	2009	1.03
4	Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.	Am Heart J	2008	0.97
5	Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel.	Coron Artery Dis	2009	0.86